Dermatica / Weight Loss Skin Support
PERSONALISED FORMULA
The one thing this register has consistently credited Dermatica for — printing the concentrations on the page you buy from — is absent here. No active is named. No strength is given. There is no ingredients section at all. And the page's own description of the problem is one no topical can fix.
There is a real reason to hesitate. Read the finding before you buy.
ASSESSED ON 75% OF THE MODEL. 2 CRITERIA LEFT UNSCORED — SEE SCORING FOR WHY.
This appears to be the anti-ageing formula under a different headline. Read that review instead — it tells you what is in the bottle, and this page does not.
The verdict
Across three previous Dermatica reviews we made the same point every time: whatever else this company gets wrong, it prints the numbers on the page where you buy. Tretinoin 0.025–0.1%. Hydroquinone 4%. Fluocinolone 0.01%. Azelaic acid 4–20%. Nobody else in this register does it, and it is the reason all three products scored around seventy despite carrying no safety copy at all.
This page has no ingredients section. Not a thinner one — none. The heading 'Evidence-backed active ingredients' appears on the anti-ageing, melasma and skin glow pages and does not appear here. No active is named, no strength is given, and the only percentages anywhere in the visible copy belong to the over-the-counter serums advertised further down. The newest page in the range is the one that abandoned the single practice we had been holding the company up for.
The clinical problem is worse. The page explains, accurately and in its own words, that weight loss changes a face because 'the fat pads beneath your skin shrink, revealing your bone structure and leaving cheeks, temples and under-eyes looking more hollow', and because skin does not always tighten at the same rate. Both are true. Neither is treatable with a nightly cream. Lost facial fat is a volumetric deficit, and the laxity that follows substantial weight loss is a structural one; a topical retinoid does neither. It thickens the dermis modestly and improves fine lines and surface texture, which is a real but different thing.
So the page names two mechanisms, promises to 'boost collagen, support elasticity and help reduce fine lines' against them, and offers visible results in twelve weeks. Only the third of those is achievable. The most careful sentence on the page belongs to the consultant dermatologist quoted at the bottom, who says weight loss makes signs of ageing 'more noticeable' and that the formulas help texture, elasticity and radiance. That is a defensible claim. It sits underneath a headline that is not.
- The description of why weight loss changes a face is clinically accurate — shrinking fat pads, hollowing at cheeks, temples and under-eyes, and skin that does not retract at the same rate.
- It acknowledges that collagen and elastin decline with age independently of the weight change.
- The consultant dermatologist's quoted claim is carefully worded and defensible, unlike the headline.
- Twelve weeks is a realistic timeline for the one endpoint here that a topical can actually move.
- It does not name any GLP-1 drug or brand, which avoids implying a partnership or an approved indication that does not exist.
- The price is the same as the rest of the range rather than carrying a premium for a fashionable indication.
- No active ingredient is named anywhere on the page.
- No concentration is published — the practice this register has credited Dermatica for on all three other treatment pages.
- There is no ingredients section at all; the heading present on every sibling page is simply absent.
- The page attributes the problem to fat pad volume loss, which no topical treats.
- 'Boost collagen, support elasticity' is offered against post-weight-loss laxity, which a topical retinoid does not correct.
- No FAQ, on a page aimed at people with specific and answerable questions.
- No side effects, no contra-indications and no pregnancy warning — the fourth Dermatica treatment page in a row without one.
- No sunscreen instruction, on a page presumably selling a photosensitising retinoid.
- Reads as the anti-ageing page with the disclosure deleted and the headline changed.
- The audience — people partway through significant weight loss and anxious about their faces — is unusually motivated, and this is the least informative page the company runs.
Every active, assessed
- Not statedNOT PUBLISHED — NO INGREDIENTS SECTION ON THE PAGE
Unknown. Presumed to be the anti-ageing pool — tretinoin, niacinamide, azelaic acid, hydroquinone — but the page names none of them
- BENCHMARK
- The company publishes concentrations on its three other treatment pages
- ASSESSMENT
- We cannot assess what we are not told. Every other Dermatica treatment page carries an actives block with strengths attached; this one carries nothing. If the formula is the anti-ageing formula, it is a good formula and the company has simply declined to say so here. If it is something else, a buyer has no way to know. Either way this is the only page in the range where the prescription content is a blank.
| ACTIVE | CONC. | BENCHMARK | ASSESSMENT |
|---|---|---|---|
| Not statedUnknown. Presumed to be the anti-ageing pool — tretinoin, niacinamide, azelaic acid, hydroquinone — but the page names none of them | NOT PUBLISHED — NO INGREDIENTS SECTION ON THE PAGE | The company publishes concentrations on its three other treatment pages | We cannot assess what we are not told. Every other Dermatica treatment page carries an actives block with strengths attached; this one carries nothing. If the formula is the anti-ageing formula, it is a good formula and the company has simply declined to say so here. If it is something else, a buyer has no way to know. Either way this is the only page in the range where the prescription content is a blank. |
Scoring
- EVIDENCE FOR THE ACTIVEWEIGHT 30%50/100
Held up entirely by inference. If this is the anti-ageing formula then tretinoin has strong evidence for fine lines and surface texture, which is one of the three things the page promises. There is no evidence that any topical restores lost facial fat pads or corrects post-weight-loss laxity, and those are the two mechanisms the page itself leads with. Nothing is named, so nothing can be checked.
- FORMULATION INTEGRITYWEIGHT 20%55/100
Probably the same competently built SmartBase formula that scored 68 to 72 on the sibling pages — the company has one compounding operation and one base. Scored well below them because the formulation is entirely unspecified here: no actives, no strengths, and the same unpublished INCI as everywhere else. A formula you cannot identify cannot be credited.
- DISCLOSUREWEIGHT 15%20/100
The worst in the range by a wide margin and among the worst in the register. No active named, no concentration, no ingredients section, no FAQ, no side effects, no contra-indications, no pregnancy warning, no sunscreen instruction, no INCI, no fill size. The disclosures on this page are the price, the billing cadence and the delivery interval.
- TOLERANCE IN USEWEIGHT 15%NOT ASSESSED
Not assessed, and not assessable — tolerance is a property of a formula, and no formula is specified.
- TEXTURE & WEARWEIGHT 10%NOT ASSESSED
Not assessed. Requires the product in hand.
- COST PER APPLICATIONWEIGHT 10%35/100
The same $29.95 a month as the three sibling products, for the only one that will not tell you what it contains. If it is the anti-ageing formula, the anti-ageing page sells the same thing at the same price and publishes the strengths. Paying identical money for strictly less information is the definition of poor value, and no fill size is published here either.
What it is
A compounded prescription night cream aimed at facial changes during weight loss, prescribed after an online consultation, at $29.95 a month following a $4.99 first month. Two bottles ship every 56 days. What is in the bottles is not stated.
The disclosure we credited them for is gone
This needs stating carefully, because it is the reverse of the finding we have made three times about this company.
The anti-ageing page publishes four actives with strengths. The melasma page publishes five, including a corticosteroid's. The skin glow page publishes two. All three carry a section headed 'Evidence-backed active ingredients', with a card per active giving targets, strength and a mechanism note. We called that the best composition disclosure in the register and built most of Dermatica's credit on it.
Counted in the visible copy of each treatment page, 27 July 2026. The percentages that do appear on the weight-loss page — 0.05%, 0.2%, 15–20% — all belong to over-the-counter serums advertised further down it. The prescription formula it sells is unnamed.
There is no ingredients section on this page. Not an abbreviated one — the heading does not appear, the cards do not appear, and no active is named in any other part of the copy either. A reader is told they will receive 'a personalized formula with active ingredients' and that is the entire specification.
This indication is flagged 'New' in Dermatica's own navigation. It is also the only one of the four without an actives block, without an FAQ, without a side-effect line and without a stated timeline for anything except results. Whatever process produced the other three pages was not applied to this one, and the direction of travel is the wrong way.
The page describes a problem its product cannot treat
Here is the page's own explanation, quoted in full because it is the crux of the review and because it is, on its own terms, correct:
Losing weight (whether it's naturally or with weight loss treatments) may cause your skin to look loose and thin, with the signs of aging becoming more pronounced. That's because the fat pads beneath your skin shrink, revealing your bone structure and leaving cheeks, temples and under-eyes looking more hollow. And as your weight drops, your skin may not always tighten at the same rate.
Dermatica, weight loss skin support page
That is a good description of what happens to a face during substantial weight loss, and better than most consumer copy on the subject. It identifies two mechanisms: loss of subcutaneous facial fat, and skin that no longer fits the volume beneath it.
Neither is a topical problem. Facial fat pads are not restored by anything applied to the surface of the skin — that is what volumising procedures exist for. And the laxity that follows a significant weight change is a matter of skin surface area exceeding the structure underneath, which no cream retracts. Topical tretinoin does produce a measurable increase in dermal collagen, and it genuinely improves fine lines, roughness and mottled pigment. Those are worthwhile and they are not the same thing as hollow temples.
Dr Shendy Engelina is quoted lower down the page: 'Weight loss can make signs of aging more noticeable. Our personalized formulas include active ingredients that support collagen production and help improve skin texture, elasticity and overall radiance.' Read that carefully — it says weight loss makes existing ageing more visible, and that the formula treats the ageing. That is accurate and it is a fair thing to sell. The headline above it says the formula is there to 'boost collagen, support elasticity and help reduce fine lines' in response to shrinking fat pads. The clinician's sentence is the honest version, and it is the one in smaller type.
It is the anti-ageing page with the numbers taken out
Compare the two hero lines. Anti-ageing: 'Get a personalized formula with active ingredients to reduce wrinkles, smooth fine lines and fade dark spots, with visible results within 12 weeks.' Weight loss: 'Get a personalized formula with active ingredients to boost collagen, support elasticity and help reduce fine lines with visible results within 12 weeks.'
Same construction, same twelve weeks, same $29.95, same SmartBase paragraph, same three-step process, same badge strip, same 'up to 20x stronger than the high street', same routine essentials, same testimonials. The difference is that one of them tells you it contains tretinoin at 0.025–0.1% and the other tells you nothing.
We think the most likely explanation is mundane: a new landing page built quickly from an existing template for a market that is growing fast, with the ingredient module not yet wired up. That is a better explanation than deliberate concealment, and it is consistent with everything else we know about this company, which discloses more than its competitors rather than less.
It does not change what a buyer gets. Someone arriving from a weight-loss search reads a page with no ingredients, no side effects and no warnings, and pays the same price as someone two clicks away who is told all three. If it is the same formula, say so and print the strengths. If it is not, that is a more serious problem than a missing module.
Fourth page, fourth missing pregnancy warning
We have now searched four Dermatica treatment pages and found no pregnancy contra-indication on any of them. That pattern is no longer notable in itself, but this page adds something to it.
The audience here is people who are losing weight, a large share of them on GLP-1 receptor agonists. Those drugs carry their own pregnancy guidance and are commonly discontinued before conception, which means a meaningful number of readers are people actively thinking about pregnancy timing. That is precisely the reader for whom a retinoid warning is load-bearing, and this is the page that does not carry one — nor a side-effect line, nor an FAQ in which to put one.
If you are considering it
- Ask which actives and which strengths you are being prescribed, before you pay. On this page that is not optional diligence, it is the only way to know what you are buying.
- Compare the answer against the anti-ageing page. If it is the same formula, buy from whichever page you like, but read that one first because it publishes the numbers.
- Separate your complaint into parts. Fine lines, texture and tone are treatable with what this company sells. Hollow cheeks, temples and under-eyes are not.
- If hollowing is the main thing, this is not the product and no topical is. Speak to someone who does volumising procedures, or decide it is fine.
- If you are pregnant, breastfeeding or planning conception, raise it unprompted. Nothing here will ask.
- Buy sunscreen. This page does not mention it and the likely active makes you burn more easily.
- Give it twelve weeks and judge it on lines and texture, which is the part that can work.
Where we stand
At 43 this is the first Dermatica product we have marked CAUTION, and it breaks a very tight cluster — the other three sit at 69, 70 and 71. That spread is the finding. A company whose consistency we praised three times has a floor much lower than its consistency suggested, and it is exactly where the commercial pressure is newest.
The caution is not that the product is dangerous. It is probably the same well-made formula as the anti-ageing cream, at a fair price, from a company that discloses more than anyone else in this register. The caution is that this page sells it against a mechanism it does not address, to a motivated audience, with less information than any other page the same company publishes — and that a reader who cannot see the ingredients cannot make any of the judgements the rest of the site is unusually good at enabling.
The fix is smaller than the score suggests. Put the actives block back. Say plainly that the treatable part is lines, texture and tone, and that hollowing is volume and needs something else. Add the pregnancy warning that already exists on the tretinoin ingredient page. Do that and this returns to the seventy that the rest of the range earns — because the formula behind it almost certainly already deserves it.
Who this is for
- Someone who has read the anti-ageing review, wants that formula, and understands this is most likely the same product reached by a different door.
- Someone whose actual complaint is fine lines and surface texture rather than hollowing, and who knows the difference.
- Someone who will ask, before paying, exactly which actives and strengths they are being prescribed — and get it in writing.
- Your concern is hollow cheeks, temples or under-eyes. That is volume loss and no cream addresses it; the honest options are volumising procedures or leaving it alone.
- Your concern is jawline or neck laxity after substantial weight loss. A topical will not tighten that either.
- You are pregnant, breastfeeding or trying to conceive. Nothing on this page will warn you, and the likely formula contains a retinoid.
- You want to know what you are being sold before you buy it. This page will not tell you.
- You would be better served buying the same formula from the anti-ageing page, where the strengths are printed.
This appears to be the anti-ageing formula under a different headline. Read that review instead — it tells you what is in the bottle, and this page does not.
This is an editorial assessment of published information about a prescription product. It is not a diagnosis, not a prescription and not a substitute for your own prescriber. Hydroquinone and tretinoin are drugs. Decisions about them belong with a clinician who has seen your skin.
Sources
- S-01Dermatica — weight loss skin support treatment page The absence of any actives block, FAQ, side-effect content, pregnancy warning or sunscreen instruction; the fat-pad explanation quoted in full; the twelve-week claim; the Dr Engelina quotation; and the $29.95 pricing. Read 27 July 2026.
- S-02Dermatica — anti-ageing treatment page The template this page appears to derive from, carrying four named actives with strengths and a near-identical hero line and twelve-week claim.
- S-03Dermatica — melasma treatment page Five named actives with concentrations, used in the Fig. 1 comparison.
- S-04Dermatica — skin glow treatment page Two named actives with ranges, used in the Fig. 1 comparison.
- S-05Dermatica — tretinoin ingredient page Where the pregnancy and contraception warning, the side-effect list and the sunscreen instruction exist on this site — none of which reach this treatment page.